At present though, we cannot formally identify which ligand has potential tumour suppressor function since other TGF-β superfamily members can also activate canonical PO4-SMAD2 and 3 via their own distinct serine threonine receptor kinase complexes including Activin, Nodal, and GDF-8 (myostatin) [31]. This evidence concerns the gene SMAD2 and neoplasm.